“We’ve compensated for the past years when the group (i.e. Ranbaxy) didn’t receive dividends,” said Dragos Damian, general manager of Terapia Ranbaxy.
“Until now, the group has decided the profits should be kept in the company and reinvested, although we don’t receive any fiscal incentives,” he told Mediafax.
Terapia Ranbaxy will distribute a gross dividend of RON0.82 per share from its net profits for 2011, 2012 and 2013.
Terapia is 96.7%-owned by Ranbaxy Laboratories, which is controlled by Japanese pharmaceuticals group Daiichi Sankyo.